Key Highlights

  • Hydrix Medical secured a multi-year remote cardiac monitoring contract in Singapore.
  • The estimated contract value is approximately AUD 0.625mn over three years, subject to patient volumes.
  • The agreement represents annual Recurring Revenue of approximately AUD 0.21mn over the term.
  • Implementation is expected to commence shortly, with revenue beginning after deployment.

Hydrix Limited (ASX:HYD) has secured a three-year remote cardiac monitoring contract through its wholly owned Hydrix Medical subsidiary. The agreement with National Heart Centre Singapore carries an estimated value of approximately AUD 0.625mn, subject to the number of patients monitored, and is expected to contribute annual recurring revenue of about AUD 0.21mn after implementation.

Company Business

The contract covers deployment of the Implicity cloud-based platform for patients with cardiac implantable electronic devices. These devices include pacemakers, implantable cardioverter defibrillators and cardiac resynchronisation therapy systems.

Implicity aggregates and standardises information from major device manufacturers within a single interface. The platform is designed to support clinical workflows and earlier intervention by bringing remote cardiac-device data together for review.

Cloud deployment will be delivered by Implicity and Hydrix Medical, with implementation expected to begin shortly. Revenue will flow to Hydrix after the system is implemented, while final contract value will vary with monitored patient volumes.

Sector Context

Remote monitoring allows clinicians to review device information without relying solely on scheduled in-person visits. Its commercial value depends on adoption, integration with hospital processes, data reliability and the number of patients enrolled.

Hydrix operates across medical technology, engineering, defence, industrial and Mining markets. Within healthcare, Hydrix Medical sources and distributes cardiovascular technologies, linking international products with clinical customers.

Risks to Consider

The AUD 0.625mn figure is an estimate rather than fixed revenue because pricing and patient numbers influence the amount recognised. Delays in implementation or slower enrolment could affect timing and value.

Cloud-based healthcare platforms also carry data-security, privacy, integration and regulatory requirements. Performance depends partly on third-party technology and the continuing commercial relationship with the platform provider and hospital.

What to Watch Next

The first milestone is implementation at the Singapore centre and commencement of revenue. Later disclosures may show the pace of patient onboarding and whether activity aligns with the stated annual recurring revenue estimate.

The hospital may also serve as a reference site for regional expansion. Any additional contracts should be assessed by term, implementation status, patient-linked pricing and recognised revenue.